≡

Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP)

[Edit]

MAC-2-BP; LGALS3-BP; Galectin-3-Binding Protein; L3 Antigen; Mac-2-Binding Protein; Tumor-associated antigen 90K; Serum Protein 90K; Basement membrane autoantigen p105

Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP)
CCC B766
HGNC 6564
MGI 99554
PubMed 23443559
RGD 620837
UniProt Q08380
Wiki LGALS3BP

Galectin-3-binding protein is a protein encoded by the LGALS3BP gene.The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. LGALS3BP has been found elevated in the serum of patients with cancer and in those infected by the human immunodeficiency virus (HIV).

It appears to be implicated in immune response associated with natural killer (NK) and lymphokine-activated killer (LAK) cell cytotoxicity. Using fluorescence in situ hybridization the full length 90K cDNA has been localized to chromosome 17q25. The native protein binds specifically to a human macrophage-associated lectin known as Mac-2 and also binds galectin 1.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPB766Hu01 Recombinant Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAB766Hu01 Polyclonal Antibody to Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) WB; IHC; ICC; IP.
MAB766Hu22 Monoclonal Antibody to Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) WB; IHC; ICC; IP.
MAB766Hu21 Monoclonal Antibody to Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) WB,IHC
LAB766Hu72 Biotin-Linked Monoclonal Antibody to Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) WB; IHC; ICC.
Assay Kits SEB766Hu ELISA Kit for Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPB766Mu01 Recombinant Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) Positive Control; Immunogen; SDS-PAGE; WB.
RPB766Mu02 Recombinant Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAB766Mu01 Polyclonal Antibody to Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) WB; IHC; ICC; IP.
PAB766Mu02 Polyclonal Antibody to Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) WB; IHC; ICC; IP.
Assay Kits SEB766Mu ELISA Kit for Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) Polyclonal Antibody Customized Service Offer
Assay Kits SEB766Ra ELISA Kit for Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP) Enzyme-linked immunosorbent assay for Antigen Detection.
  1. "Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain."J. Biol. Chem. 268:14245-14249(1993) [PubMed] [Europe PMC] [Abstract]
  2. "The secreted tumor-associated antigen 90K is a potent immune stimulator."J. Biol. Chem. 269:18401-18407(1994) [PubMed] [Europe PMC] [Abstract]
  3. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  4. "Purification and characterization of a 90 kDa protein released from human tumors and tumor cell lines."FEBS Lett. 319:59-65(1993) [PubMed] [Europe PMC] [Abstract]
  5. "The 105-kDa basement membrane autoantigen p105 is N-terminally homologous to a tumor-associated antigen."J. Invest. Dermatol. 107:209-214(1996) [PubMed] [Europe PMC] [Abstract]
  6. "Functional studies on recombinant domains of Mac-2-binding protein."J. Biol. Chem. 277:15690-15696(2002) [PubMed] [Europe PMC] [Abstract]
  7. "Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation."Int. J. Cancer 91:167-172(2001) [PubMed] [Europe PMC] [Abstract]
  8. "A proteomic analysis of human bile."Mol. Cell. Proteomics 3:715-728(2004) [PubMed] [Europe PMC] [Abstract]
  9. "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry."J. Proteome Res. 4:2070-2080(2005) [PubMed] [Europe PMC] [Abstract]
  10. "Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry."J. Proteome Res. 5:1493-1503(2006) [PubMed] [Europe PMC] [Abstract]
  11. "Identification of N-linked glycoproteins in human milk by hydrophilic interaction liquid chromatography and mass spectrometry."Proteomics 8:3833-3847(2008) [PubMed] [Europe PMC] [Abstract]
  12. "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
  13. "A strategy for precise and large scale identification of core fucosylated glycoproteins."Mol. Cell. Proteomics 8:913-923(2009) [PubMed] [Europe PMC] [Abstract]
  14. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  15. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
  16. "Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin."EMBO J. 17:1606-1613(1998) [PubMed] [Europe PMC] [Abstract]